15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          N6-methyladenosine (m6A) RNA methylation and its associated methyltransferase METTL3 are involved in tumour initiation and progression via the regulation of RNA function. This study explored the biological function and clinical significance of METTL3 in gastric cancer (GC).

          Related collections

          Author and article information

          Journal
          Gut
          Gut
          BMJ
          1468-3288
          0017-5749
          July 2020
          : 69
          : 7
          Affiliations
          [1 ] Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, People's Republic of China.
          [2 ] Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center; School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China.
          [3 ] Department of Geriatric Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China.
          [4 ] Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, People's Republic of China.
          [5 ] Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, People's Republic of China.
          [6 ] Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, People's Republic of China sywang@nju.edu.cn sunbc@njmu.edu.cn 13770771661@163.com.
          [7 ] Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, People's Republic of China sywang@nju.edu.cn sunbc@njmu.edu.cn 13770771661@163.com.
          [8 ] Center for Public Health Research, Medical School of Nanjing University, Nanjing, Jiangsu Province, People's Republic of China.
          [9 ] Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu Province, People's Republic of China.
          Article
          gutjnl-2019-319639
          10.1136/gutjnl-2019-319639
          31582403
          788e3483-a5a1-4a1c-a5bd-091fa10b222a
          © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
          History

          METTL3,angiogenesis,gastric cancer,glycolysis,m6A
          METTL3, angiogenesis, gastric cancer, glycolysis, m6A

          Comments

          Comment on this article